Genetic Technologies Limited (GNTLF)
USD 1.0
(0.0%)
USD 1.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -12.01 Million AUD | -2.27% |
| 2023 | -11.75 Million AUD | -64.79% |
| 2022 | -7.13 Million AUD | -0.75% |
| 2021 | -7.07 Million AUD | -16.05% |
| 2020 | -6.09 Million AUD | 5.08% |
| 2019 | -6.42 Million AUD | -17.6% |
| 2018 | -5.46 Million AUD | 34.98% |
| 2017 | -8.4 Million AUD | 0.65% |
| 2016 | -8.45 Million AUD | 3.99% |
| 2015 | -8.81 Million AUD | 12.99% |
| 2014 | -10.12 Million AUD | -8.3% |
| 2013 | -9.34 Million AUD | -76.82% |
| 2012 | -5.28 Million AUD | -681.05% |
| 2011 | 910 Thousand AUD | 109.74% |
| 2010 | -9.34 Million AUD | 3.83% |
| 2009 | -9.71 Million AUD | -78.02% |
| 2008 | -5.45 Million AUD | -227.66% |
| 2007 | -1.66 Million AUD | 69.26% |
| 2006 | -5.41 Million AUD | 28.07% |
| 2005 | -7.53 Million AUD | -9.32% |
| 2004 | -6.88 Million AUD | -59.28% |
| 2003 | -4.32 Million AUD | 50.99% |
| 2002 | -8.82 Million AUD | -160.28% |
| 2001 | -3.39 Million AUD | -38.97% |
| 2000 | -2.43 Million AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 FY | -12.01 Million AUD | -2.27% |
| 2024 Q2 | -6.41 Million AUD | -100.0% |
| 2024 Q1 | -3.2 Million AUD | 48.98% |
| 2024 Q4 | -5.59 Million AUD | 0.0% |
| 2023 Q1 | -2.73 Million AUD | 15.99% |
| 2023 Q3 | -3.14 Million AUD | 42.4% |
| 2023 Q2 | -5.46 Million AUD | -100.0% |
| 2023 FY | -11.75 Million AUD | -64.79% |
| 2023 Q4 | -6.29 Million AUD | -100.0% |
| 2022 Q3 | -1.62 Million AUD | 58.14% |
| 2022 Q1 | -1.94 Million AUD | 46.13% |
| 2022 FY | -7.13 Million AUD | -0.75% |
| 2022 Q2 | -3.88 Million AUD | -100.0% |
| 2022 Q4 | -3.24 Million AUD | -100.0% |
| 2021 Q4 | -3.6 Million AUD | -100.0% |
| 2021 Q1 | -1.73 Million AUD | 49.65% |
| 2021 Q2 | -3.47 Million AUD | -100.0% |
| 2021 Q3 | -1.8 Million AUD | 48.17% |
| 2021 FY | -7.07 Million AUD | -16.05% |
| 2020 Q1 | -1.32 Million AUD | 59.91% |
| 2020 Q2 | -2.64 Million AUD | -100.0% |
| 2020 Q3 | -1.82 Million AUD | 31.13% |
| 2020 Q4 | -3.45 Million AUD | -89.26% |
| 2020 FY | -6.09 Million AUD | 5.08% |
| 2019 Q4 | -3.3 Million AUD | -100.0% |
| 2019 Q1 | -1.56 Million AUD | -44.31% |
| 2019 Q2 | -1.56 Million AUD | 0.0% |
| 2019 FY | -6.42 Million AUD | -17.6% |
| 2019 Q3 | -1.65 Million AUD | -5.73% |
| 2018 Q3 | -1.08 Million AUD | 34.4% |
| 2018 Q1 | -1.64 Million AUD | 23.82% |
| 2018 FY | -5.46 Million AUD | 34.98% |
| 2018 Q2 | -1.64 Million AUD | 0.0% |
| 2018 Q4 | -1.08 Million AUD | 0.0% |
| 2017 Q2 | -2.03 Million AUD | 0.0% |
| 2017 FY | -8.4 Million AUD | 0.65% |
| 2017 Q4 | -2.16 Million AUD | 0.0% |
| 2017 Q3 | -2.16 Million AUD | -6.36% |
| 2017 Q1 | -2.03 Million AUD | 0.97% |
| 2016 Q3 | -2.05 Million AUD | 5.39% |
| 2016 Q4 | -2.05 Million AUD | 0.0% |
| 2016 Q2 | -2.17 Million AUD | 0.0% |
| 2016 Q1 | -2.17 Million AUD | -9.25% |
| 2016 FY | -8.45 Million AUD | 3.99% |
| 2015 FY | -8.81 Million AUD | 12.99% |
| 2015 Q4 | -1.98 Million AUD | 0.0% |
| 2015 Q3 | -1.98 Million AUD | 17.65% |
| 2015 Q2 | -2.41 Million AUD | 0.0% |
| 2015 Q1 | -2.41 Million AUD | 3.87% |
| 2014 Q4 | -2.51 Million AUD | 0.0% |
| 2014 FY | -10.12 Million AUD | -8.3% |
| 2014 Q1 | -2.54 Million AUD | 8.68% |
| 2014 Q2 | -2.54 Million AUD | 0.0% |
| 2014 Q3 | -2.51 Million AUD | 1.43% |
| 2013 FY | -9.34 Million AUD | -76.82% |
| 2013 Q4 | -2.79 Million AUD | 0.0% |
| 2013 Q3 | -2.79 Million AUD | 0.0% |
| 2012 Q2 | - AUD | 0.0% |
| 2012 FY | -5.28 Million AUD | -681.05% |
| 2012 Q3 | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2011 FY | 910 Thousand AUD | 109.74% |
| 2011 Q2 | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 FY | -9.34 Million AUD | 3.83% |
| 2009 Q4 | - AUD | 0.0% |
| 2009 FY | -9.71 Million AUD | -78.02% |
| 2008 FY | -5.45 Million AUD | -227.66% |
| 2008 Q2 | -226.83 Thousand AUD | 0.04% |
| 2008 Q1 | -226.91 Thousand AUD | -119.92% |
| 2008 Q4 | -2.5 Million AUD | 0.01% |
| 2008 Q3 | -2.5 Million AUD | -1002.98% |
| 2007 Q1 | -3.55 Million AUD | -196.57% |
| 2007 FY | -1.66 Million AUD | 69.26% |
| 2007 Q2 | -2.65 Million AUD | 25.26% |
| 2007 Q3 | 1.39 Million AUD | 152.33% |
| 2007 Q4 | 1.13 Million AUD | -18.13% |
| 2006 FY | -5.41 Million AUD | 28.07% |
| 2006 Q1 | -1.53 Million AUD | -215.27% |
| 2006 Q2 | -1.53 Million AUD | -0.01% |
| 2006 Q3 | -1.4 Million AUD | 8.62% |
| 2006 Q4 | -1.19 Million AUD | 14.72% |
| 2005 Q2 | -264.78 Thousand AUD | 6.74% |
| 2005 FY | -7.53 Million AUD | -9.32% |
| 2005 Q1 | -283.92 Thousand AUD | 0.0% |
| 2005 Q3 | -6.5 Million AUD | -2358.14% |
| 2005 Q4 | -488.07 Thousand AUD | 92.5% |
| 2004 FY | -6.88 Million AUD | -59.28% |
| 2003 FY | -4.32 Million AUD | 50.99% |
| 2002 FY | -8.82 Million AUD | -160.28% |
| 2001 FY | -3.39 Million AUD | -38.97% |
| 2000 FY | -2.43 Million AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.41 Million USD | -752.285% |
| Arrayit Corporation | -3.31 Million USD | -262.445% |
| Atlantic International Corp. | -5.62 Million USD | -113.541% |
| Biocept, Inc. | -32.08 Million USD | 62.548% |
| Bioqual, Inc. | 483.48 Thousand USD | 2585.562% |
| CardioGenics Holdings Inc | -1.91 Million USD | -527.097% |
| DermTech, Inc. | -100.88 Million USD | 88.089% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion USD | 100.593% |
| HTG Molecular Diagnostics, Inc. | -21.59 Million USD | 44.35% |
| iMD Companies, Inc. | -200.63 Thousand USD | -5889.563% |
| IDenta Corp. | 14.64 Thousand USD | 82162.408% |
| Interpace Biosciences, Inc. | 802 Thousand USD | 1598.406% |
| Integrative Health Technologies, Inc. | 38.68 Thousand USD | 31161.074% |
| InVitro International | 1553.00 USD | 773906.761% |
| Lumos Diagnostics Holdings Limited | -8.59 Million USD | -39.865% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -20579.41% |
| Medical Imaging Corp. | -3.02 Million USD | -297.523% |
| NovelStem International Corp. | -4.18 Million USD | -186.992% |
| Optigenex Inc. | -2.89 Million USD | -314.707% |
| PharmChem, Inc. | 845.1 Thousand USD | 1521.984% |
| Proteome Sciences plc | -2.44 Million USD | -391.904% |
| Response Genetics, Inc | -20.18 Million USD | 40.462% |
| Rennova Health, Inc. | -3.29 Million USD | -264.926% |
| RushNet, Inc. | -607.02 Thousand USD | -1879.681% |
| ScreenPro Security Inc. | -2.24 Million USD | -434.391% |
| Stella Diagnostics Inc. | -5.7 Million USD | -110.554% |
| StageZero Life Sciences Ltd. | -11.41 Million USD | -5.272% |
| Todos Medical Ltd. | -24.99 Million USD | 51.92% |